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La scienza è fatta di dati,  
come una casa di pietre.  
Ma un ammasso di dati non è scienza  
più di quanto un mucchio di pietre sia una casa. 
 
(Henri Poincaré, La scienza e l'ipotesi, 1902) 
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Riassunto 
Il 7-deidrocolesterolo (7-DHC), il precursore biosintetico del 
colesterolo, è una molecola che si modifica facilmente producendo 
composti ossidati. Prove in vitro hanno dimostrato che l'instabilità del 7-
DHC in soluzione e nei liposomi è dovuta alla sua suscettibilità alla 
perossidazione. Inoltre, il 7-DHC è convertito nella vitamina D3 mediante 
la sintesi foto-indotta che avviene nella pelle. Il 7-DHC che è presente a 
concentrazioni relativamente elevate nella pelle, è esposto all’attacco dei 
radicali esogeni e dall’ossigeno. Recentemente è stato riportato che i 
composti ossidati del 7-DHC possono esercitare effetti deleteri sulla 
funzionalità e sulla vitalità cellulare.  
Le radiazioni ultraviolette rappresentano la causa principale dei tumori 
della pelle ed il melanoma ne è la forma più grave. La diagnosi tardiva del 
melanoma è particolarmente infausta in quanto tale neoplasia nello stadio 
avanzato è refrattario alle terapie.  
In questo studio abbiamo valutato l'effetto del 7-DHC “come tale” (non 
modificato) su linee cellulari di melanoma ed a tale scopo è stata posta 
molta attenzione a minimizzare le modifiche del 7-DHC. Abbiamo quindi 
valutato la stabilità del 7-DHC nella sospensione del veicolo utilizzata per 
il trasferimento del 7-DHC dal mezzo di coltura all’interno delle cellule. 
Inoltre, abbiamo determinato i livelli intracellulari del 7-DHC e dei suoi 
composti derivati  dopo diversi tempi di trattamento. 
Lo studio di stabilità nel tempo non ha mostrato variazioni significative 
dei livelli del 7-DHC nella sospensione conservata per 90 giorni a 4 °C. 
Abbiamo osservato che da 12 a 72 ore di trattamento l’82-86% di 7-DHC 
entrava nelle cellule ed i livelli dei composti derivati dal 7-DHC non 
erano significativi. Allo stesso tempo, la produzione di ROS aumentava in 
modo significativo già dopo 2 ore. Dopo 24 ore e fino a 72 ore, le cellule 
di melanoma trattate con 7-DHC hanno mostrato una riduzione della 
crescita e della vitalità cellulare. L'effetto citotossico del 7-DHC era 
associato ad aumento dei livelli di Bax, diminuzione del rapporto Bcl-
2/Bax, riduzione del potenziale di membrana mitocondriale, aumento dei 
livelli del fattore che induce apoptosi (AIF), a nessuna variazione 
dell’attività della caspasi-3 così come all’assenza della forma inattiva di 
PARP-1. Tali risultati contribuiscono a spiegare il meccanismo attraverso 
il quale il 7-DHC esercita il suo effetto citotossico.  
Nel complesso i risultati ottenuti nel corso di questo lavoro indicano che 
il 7-DHC esercita un effetto citotossico su linee cellulari di melanoma, 
probabilmente attraverso un processo pro-apoptotico caspasi indipendente 
e allargano le conoscenze sulle prospettive terapeutiche del cancro. 
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Summary 
The 7-dehydrocholesterol (7-DHC), the precursor of cholesterol 
biosynthesis, is highly reactive and easily modifiable to produce 7-DHC 
oxidative compounds. Evidences in vitro demonstrated that the instability 
of 7-DHC in solution and in liposomes is due to its susceptibility to 
peroxidation. In addition, 7-DHC is also converted in vitamin D3 by 
photo-induced synthesis which occurs in the skin. 7-DHC is present at 
relatively high concentrations in skin where it is exposed to exogenous 
radical sources and oxygen. Recently, it has been reported that 7-DHC 
oxidative compounds can have deleterious effects on cellular 
functionality and viability.  
Ultraviolet radiation is the main cause of skin cancers, and melanoma is 
the most serious form of tumor. Today, there is no therapy for advanced-
stage melanoma and its metastasis due to their high resistance to various 
anticancer therapies.  
In this study, we evaluated the effect on melanoma cell lines of 7-DHC as 
such, and for this aim much care to minimize 7-DHC modifications was 
used. Therefore, we evaluated the 7-DHC stability in the vehicle 
suspension used to transfer this compound from the culture medium into 
the cells. We also measured the intracellular levels of 7-DHC and its 
oxidative compounds after different treatment times. 
The stability study showed no significant changes of 7-DHC levels from 
baseline values in the suspension up to 90 days of storage at 4 °C. 
We found that from 12 to 72 hours of treatment 82-86% of 7-DHC 
entered the cells, and the levels of 7-DHC-derived compounds were not 
significant. Simultaneously, ROS production was significantly increased 
already after 2 hours. After 24 hours and up to 72 hours, 7-DHC treated 
melanoma cells showed a reduction of cell growth and viability. The 
cytotoxic effect of 7-DHC was associated with the increase of Bax levels, 
the decrease of Bcl-2/Bax ratio, the reduction of mitochondrial membrane 
potential, the increase of apoptosis inducing factor (AIF) levels, the 
unchanged caspase-3 activity, and uncleavage of PARP-1. These findings 
could explain the mechanism through which 7-DHC exerts its cytotoxic 
effect.  
The results of this study show that the 7-DHC has a potential pro-
apoptotic on melanoma cell lines, shed light on the possible mechanisms 
through which this molecule exerts its cytotoxic effects and, at same time, 
may give new insights in the therapeutic perspective of cancer. 
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1. Introduction 
 
1.1 7-Dehydrocholesterol and its oxidative compounds 
The 7-dehydrocholesterol (7-DHC) is the direct precursor of 
cholesterol and contains an unsaturated B ring with two double bonds in 
position 5 and 7, which is reduced by delta7-sterol reductase to produce 
cholesterol [1,2]. Inherited defects in this enzyme reduce or abolish the 
transformation of 7-DHC to cholesterol with accumulation of 7-DHC and 
its isomer 8-dehydrocholesterol (8-DHC), in blood and tissues, well 
described in the Smith Lemli Opitz syndrome (SLOS; MIM 270400). 
Patients affected by this disorder have multiple morphogenic and 
congenital anomalies including internal organ, skeletal and/or skin 
abnormalities [3]. Clinical severity correlates negatively with the 
cholesterol concentration, and positively with the 7-DHC concentration 
and the sum of dehydrocholesterols (DHC) [4]. 
In a previous study we described our experience in laboratory diagnosis 
of SLOS and other defects of cholesterol biosynthesis analyzing the sterol 
profiles in plasma and erythrocyte membranes by gas chromatography 
paired to mass spectrometry (GC-MS). In particular, we measured 
cholesterol and its precursors, such as 7-DHC, desmosterol, 8-DHC, 
lathosterol, and exogenous sterols, such as campesterol, stigmasterol, and 
sitosterol. Furthermore, in order to ascertain the stability of the DHC, we 
evaluated storage effects on cholesterol and DHC concentrations in 
plasma and erythrocyte membranes from SLOS and unaffected subjects. 
We observed that the oxidation rate of DHC in erythrocyte membranes 
was at least 2-fold higher than that in plasma [5]. From our experience 
and according to others, DHC in plasma are relatively stable, but 
substantial autoxidation would be expected for DHC in plasma and whole 
blood adsorbed onto filter paper and exposed to air for long periods of 
time [6,7]. Based on these results, we have recently developed a 
procedure to stabilize DHC in dried spot of blood from patients with 
SLOS using a filter-paper treated with butylated hydroxytoluene as 
antioxidant [8,9]. 
Autoxidation of lipids, such as polyunsaturated fatty acids (PUFAs) and 
sterols, has attracted research attention over the last few decades due to its 
involvement in the patho-physiology of common diseases. Lipids are 
extremely prone to react with molecular oxygen and cholesterol free 
radical oxidation has been studied in great detail because some of its 
peroxide products have potent biological activities [10,11]. 
Experimental evidences in vitro demonstrated that the instability of 7-
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DHC in solution and in liposomes is due to its susceptibility to 
peroxidation, which is at least 10-fold more reactive than arachidonic 
acid, and at least 200-fold more reactive than cholesterol [12]. Recently, 
over a dozen oxysterols were isolated and characterized from free radical 
chain oxidation of 7-DHC [13]. 
In addition, 7-DHC is also known as pro-vitamin D, the precursor of 
vitamin D3 (cholecalciferol). The photochemical isomerization of 7-DHC 
after absorption of UV-B photons to the pre-vitamin D3 intermediate, 
followed by its slow isomerization to three main products including 
vitamin D3, tachysterol, and lumisterol (L3), represents the most 
fundamental reactions in the photobiology of the skin [14]. Increasing 
evidences indicate that the UV-B-mediated cutaneous photosynthesis of 
1,25-dihydroxyvitamin D3 (1,25(OH)2D3), the active form of vitamin D, 
represents an evolutionary highly conserved endocrine system that 
protects the skin against environmental hazards, including UV [15-19]. 
Human skin is a fundamental body organ involved in the internal 
homeostasis by separating the external from the internal environments, 
and through its immune and neuroendocrine activities [20]. The skin is an 
organ frequently exposed to sunlight and it is well known that ultraviolet 
radiation is the main cause of skin cell damage that ultimately leads to 
skin cancer. Indeed, the melanocytes, pigment-producing cells in the skin, 
can transform into melanoma cells, the most serious form of skin cancer. 
When detected early, melanoma is considered curable, but when detected 
at later stages it is one of the most lethal malignancies. Surgery is 
standard treatment for localized melanoma; unfortunately, there is no 
standard therapy for advanced-stage melanoma. Metastatic melanoma 
disseminates widely and it frequently involves sites that are not 
commonly affected in other cancers, such as the gastrointestinal tract and 
skin. Systemic therapies are known to be ineffective, because of the high 
resistance of melanoma cells to various anticancer therapies [21]. 
 
 
1.2 Effects of 7-DHC and its derivative compounds  
7-DHC is present at relatively high concentrations in skin where it 
is exposed to exogenous radical sources and oxygen. The intracellular 
levels of 7-DHC could have deleterious effects on cellular functionality, 
either through altering the composition of the membranes or causing an 
intracellular redox imbalance. In addition, 7-DHC oxidative derivatives, 
oxysterols, can affect the cellular viability inducing cytotoxicity [22], the 
immune response [23], and influencing the regulation of cholesterol 
homeostasis [24,25]. However, the study of the effects on cancer cells, 
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stimulated by the addition of 7-DHC alone to culture medium is rarely 
reported in the literature.  
In keratinocytes, when cholesterol is partially replaced by 7-DHC, a rapid 
increase of intracellular ROS levels has been observed [26]. Since 7-DHC 
is not a chromophore, at present, it is not clear how the 7-DHC causes the 
redox state alterations responsible of UV-A skin photosensibility.  
In the membranes cholesterol can be displaced by 7-DHC and 
contributing to affect lipid raft architecture. In fact, it has been suggested 
that the alteration of signaling pathways, triggered by the modification in 
the lipid raft composition in a keratinocyte model, is associated to an 
increase of UV-A-induced ROS formation [15]. Therefore, the high levels 
of 7-DHC can provoke cellular changes through a two-step mechanism: i) 
displacing the cholesterol, 7-DHC alters the composition of cellular 
membranes, ii) the high reactivity of 7-DHC makes this molecule easily 
modifiable producing several 7-DHC-derived compounds. Recently, in 
normal cells and in a SLOS cell model it was observed that 7-DHC-
derived oxysterols altered the expression of molecules involved in the 
intracellular signaling, lipid biosynthesis, and vesicular transport [27,28]. 
 
 
1.3 Scientific hypothesis and aim of the work 
In this study we have hypothesized that the evaluation of cytotoxic 
potential of 7-DHC could be of interest in a neoplastic context.  
We have treated melanoma cell lines with 7-DHC at concentrations likely 
to that detected in plasma of SLOS patients with a mild phenotype.  
In order to understand the direct effects of 7-DHC, we evaluated the 7-
DHC stability in the vehicle suspension used to transfer the 7-DHC from 
the culture medium into the cells. 
We have studied the cytotoxic effect of 7-DHC on melanoma cells, 
evaluating its pro-apoptotic potential, and the molecular processes that 
regulate the cell death up to 3 days of treatment. 
We have measured the intracellular levels of 7-DHC and its oxidized 
derivatives after different treatment times. 
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2. Materials and Methods  
 
2.1 Materials 
The analytical solvents of HPLC grade, including methanol, 
dichloromethane, n-hexane, ethanol, and pyridine were purchased from 
Carlo Erba Reagenti (Milano, Italy). Ursodeoxycholic acid, sterol 
standards, oxysterols, butylated hydroxytoluene (BHT), and N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA) were purchased from 
Sigma–Aldrich Ltd. (St. Louis, MO, USA). Sodium ursodeoxycholate 
(NaUDC) was prepared by neutralizing ursodeoxycholic acid dissolved in 
95% ethanol with a stoichiometric amount of aqueous sodium hydroxide 
solution [29], the solution was dried under nitrogen, and dissolved in 
methanol to provide a solution of 12.4 g/L. BHT was dissolved in ethanol 
to provide a stock solution of 60 g/L. Stock solutions of sterol standards 
were prepared in chloroform/methanol (2:1, v/v) to provide solutions of 
0.4 g/L for 5-cholestane (internal standard), 1 g/L for cholesterol, and 
3.85 g/L for 7-DHC. Stock solutions of oxysterols (cholesterol 5β,6β-
epoxide, 25-hydroxy-cholesterol, and 7-keto-cholesterol) were prepared 
in methanol to provide solutions of 1 g/L. All solutions were stored at -20 
°C. Dulbecco’s modified eagle’s medium (DMEM), Roswell Park 
Memorial Institute (RPMI) 1640 medium, fetal bovine serum (FBS), L-
glutamine, penicillin G, streptomycin, trypsin were purchased from Lonza 
(Milano, Italy). Annexin V-FITC was purchased from BD Pharmigen 
(Milano, Italy). Propidium iodide (PI), dichlorofluorescein diacetate 
(DCFH-DA), Rhodamine 123 (R123), apocynin, N-acetyl-L-cysteine 
(NAC) were purchased from Sigma-Aldrich Ltd. A protease inhibitor 
cocktail was obtained from Roche Diagnostics S.p.A. (Monza, Italy). 
Caspase-3 fluorometric assay kit was purchased from BioVision 
(Milpitas, CA, USA), and EnzyChrome GSH/GSSG assay kit was 
purchased from BioAssay Systems (Hayward, CA, USA). Rabbit 
monoclonal antibody against AIF was from Abcam (Cambridge, UK); 
rabbit monoclonal antibody against GAPDH was obtained from Cell 
Signalling (Boston, MA, USA); mouse monoclonal antibody against Bcl-
2, rabbit polyclonal antibody against Bax, goat polyclonal antibody 
against -actin, rabbit polyclonal antibody against poly(ADP-ribose) 
polymerase 1 (PARP-1), and each secondary antibody conjugated to 
horseradish peroxidase were obtained from Santa Cruz Biotechnology 
(Heidelberg, Germany). All other chemicals were of analytical grade and 
were purchased from Sigma-Aldrich Ltd. 
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2.2 Preparation of 7-DHC-enriched media 
Two suspensions containing 12.4 g/L NaUDC enriched with 3.85 
g/L 7-DHC and NaUDC alone (vehicle) were prepared by a modified 
dispersion method [30,31]. Briefly, 2 mL of NaUDC alone or a mix of 2 
mL of 7-DHC and 2 mL of NaUDC were dried under nitrogen and 
dissolved with 2 mL of phosphate buffer (50 mM, pH 7.4). The 
suspensions were sterilized by autoclaving (121 °C for 20 min), and then 
mixed vigorously on a vortex, incubated at 65 °C for 15 min and 
sonicated for 20 min (three times). These suspensions were diluted 1:10 
with FBS and, after incubation at 37° C for 1.5 hours alternating with 
vortex agitation, the 7-DHC-enriched FBS and the 7-DHC-free FBS were 
diluted ten fold with medium to obtain final concentrations of 38.5 g/mL 
for 7-DHC and 124 µg/mL for NaUDC (7-DHC-enriched medium) and of 
124 µg/mL for NaUDC alone (7-DHC-free medium), respectively. To 
obtain a medium containing 19.2 µg/mL 7-DHC and 124 µg/mL NaUDC, 
the FBS containing 7-DHC at 385 g/mL was diluted (1:1) with 7-DHC-
free FBS. The solutions of 7-DHC-enriched medium and of 7-DHC-free 
medium were incubated at 4° C over-night before use. 
 
 
2.3 Cell culture 
The human melanoma cell line A2058, kindly provided from 
CEINGE (Naples, Italy) and SAN [32] were derived from lymphonodal 
metastasis. A2058 and SAN  melanoma cells were grown in DMEM or 
RPMI, respectively, supplemented with 10% FBS, 2 mM L-glutamine, 
100 IU/mL penicillin G and 100 µg/mL streptomycin in humidified 
incubator at 37 °C under 5% CO2 atmosphere. They were split and seeded 
in plates (75 cm
2
) every three days and used for assays during exponential 
phase of growth. Cell treatments were always carried after 24 hours from 
plating. A2058 or SAN cells were treated with culture media containing 
19.2 g/mL or 38.5 g/mL of 7-DHC and 124 g/mL of NaUDC, and 
with 7-DHC-free media as controls for 12, 24, 48, and 72 hours. 
 
 
2.4 MTT assay 
The 3-(4,5-dimethylthiazole-2-yl)-2,5-biphenyl-tetrazolium 
bromide (MTT) assay was used to detect cell proliferation. Cells were 
plated in 96-well at 2 x 10
4
 cells/well and after one day-plating, 7-DHC 
was added to the cultures. At the end of each incubation time, MTT assay 
was performed according to the manufacturer’s protocol. The absorbance 
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was measured at a wavelength of 570 nm with the ELISA plate reader 
(BioRad, Milano, Italy). 
 
 
2.5 LDH Assay  
A2058 cells were plated in 6-well at 1 x 10
5
 cells/well and after one 
day-plating, 7-DHC was added to the cultures and cells were incubated 
for different times. At the end of each incubation, cytotoxicity was 
quantitatively assessed by measurements of lactate dehydrogenase (LDH) 
activity released in the extracellular fluid from damaged or destroyed 
cells [33]. Briefly, different aliquots of cell incubation media were added 
to a 1-mL reaction mixture containing 0.1M Tris-HCl, pH 7.5, 125 μM 
NADH, and incubated for 15 min at 30 °C. The reaction started with the 
addition of 600 μM sodium pyruvate and was followed by the decrease in 
absorbance at 340 nm. The results were normalized to 100% death caused 
by cell sonication. 
 
 
2.6 Evaluation of Apoptosis  
Annexin V-FITC was used to evaluate apoptosis during 7-DHC 
treatment. Briefly, cells were seeded into 6-well plate (2 x 10
5
 cells/well) 
and treated with 7-DHC for 24 hours. After treatment, cells were washed 
twice with PBS, and harvested with a cell scraper. 1 x 10
5
 cells were 
resuspended in 100 L of 1 x binding buffer (10 mM Hepes pH 7.5, 140 
mM NaCl, 2.5 mM CaCl2) containing 5 L of Annexin V-FITC and 10 
L of 50 g/mL PI and incubated for 15 min at room temperature in the 
dark, and analyzed by flow cytometry. Apoptosis was further evaluated 
by determining the number of nuclei with a hypodiploid content of DNA 
using PI staining. Briefly, 7-DHC-treated cells were seeded into 96-well 
plates (2 x 10
4
 cells/well); at the end of each treatment, cell suspensions 
were centrifuged and pellets were re-suspended in a hypotonic lysis 
solution containing 50 μg/mL propidium iodide. After incubation at 4 °C 
for 30 min, cells were analyzed by flow cytometry to evaluate the 
presence of nuclei with a DNA content lower than the diploid [34]. The 
effect of 7-DHC on apoptosis was also evaluated in the presence of NAC 
as antioxidant or apocynin as inhibitor of NADPH oxidase. In particular, 
the cells were pre-incubated for 1 hour with NAC (10 mM) or 45 min 
with apocynin (0.5 mM). After, the media were withdrawn and cells were 
treated with 7-DHC. 
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2.7 Measurements of caspase-3 activity 
To evaluate caspase-3 activation during 7-DHC treatment, the 
enzymatic activity was measured by using caspase-3 fluorometric assay 
kit according to the manufacturer’s protocol. Briefly, cells were seeded 
into 75 cm
2
 plates (1 x 10
6
 cells/plate) and treated with 38.5 µg/mL 7-
DHC. At the end of incubation cells were collected, washed with PBS, 
and finally lysed at 4 °C using cell lysis buffer. Cell lysates (150 µg of 
proteins) were incubated with 50 µM DEVD-AFC substrate at 37 °C for 2 
hours, to detect caspase-3 activity. The measurements were realized with 
a Cary Eclipse fluorescence spectrophotometer (Varian). Excitation and 
emission wavelengths were 400 nm and 505 nm, respectively; both 
excitation and emission slits were set at 10 nm. 
 
 
2.8 Detection of intracellular ROS content 
The intracellular ROS level was detected using the oxidation-
sensitive fluorescence probe DCFH-DA. Briefly, A2058 cells were 
seeded into 6-well plate (1 x 10
5
 cells/well) and treated with 7-DHC for 
different times. DCFH-DA was added in the dark at 10 μM final 
concentration 30 min before the end of each incubation; then cells were 
collected, washed in 10 mM sodium phosphate, pH 7.2 buffer containing 
150 mM NaCl (PBS), and finally resuspended in 500 μL of PBS for the 
fluorimetric analysis. The measurement of the ROS levels was realized 
with a Cary Eclipse fluorescence spectrophotometer (Varian). Excitation 
and emission wavelengths were 485 nm and 530 nm, respectively; both 
excitation and emission slits were set at 10 nm. The effect of 7-DHC on 
ROS production was also evaluated pre-treating the cells with NAC (10 
mM) or apocynin (0.5 mM) for 1 hour or 45 min, respectively. After, the 
media were withdrawn and cells were treated with 7-DHC. 
 
 
2.9 Measurement of intracellular glutathione content 
Intracellular glutathione content was measured using the 
EnzyChrome GSH/GSSG assay kit. Briefly, 2 x 10
6
 cells were treated 
with 7-DHC (38.5 μg/mL) and after the incubation time they were 
sonicated and homogenized in phosphate buffer 50 mM and 1 mM 
EDTA. The suspension was centrifuged at 4° C for 15 min at 10,000 g, 
and the supernatant was deproteinized with 5% meta-phosphoric acid, 
centrifuged at 14,000 rpm for 5 min, and GSH and GSSG contents were 
measured following manufacturer’s protocol. 
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2.10 Evaluation of mitochondrial membrane potential 
Mitochondrial membrane potential was evaluated by measuring the 
incorporation of the fluorescent probe R123. Briefly, cells were seeded 
into 6-well plate (1 x 10
5
 cells/well), incubated at 37 °C for 1 hour in the 
presence of 5 µM R123, washed twice with PBS and placed in medium 
containing 7-DHC. After different times of treatment, the medium was 
withdrawn and collected cells were washed twice with PBS. After 
detachment with trypsin, cells were harvested in PBS and centrifuged at 4 
°C for 10 min. Following aspiration of supernatant, the cellular pellet was 
resuspended in 500 µL of PBS. The fluorescence of cell-associated R123 
was measured in the above-mentioned fluorescence spectrophotometer, 
using excitation and emission wavelengths of 490 nm and 520 nm, 
respectively; both excitation and emission slits were set at 10 nm. The 
fluorescence intensities were normalized versus the cell number. 
 
 
2.11 Total cell lysates and subcellular fractionation for Western blot 
analysis 
A2058 cells were plated at a density of 1 x 10
5
 cells/well in 6-well 
plates, treated and untreated cells were then harvested, washed with PBS, 
and lysed in ice-cold modified RIPA buffer (50mM Tris-HCl, pH 7.4, 
150mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycolate, 1mM 
Na3VO4, and 1mM NaF), supplemented with protease inhibitors and 
incubated for 30 min on ice. The supernatant obtained after centrifugation 
at 12,000 g for 30 min at 4 °C constituted the total protein extract. Protein 
concentration was determined by the method of Bradford [35], using BSA 
as calibrator. 
To obtain cytosolic and mithocondrial fractionation, cells were plated at a 
density of 2 x 10
6
 cells/plate (143 cm
2
). After the treatment, the cells were 
harvested, washed in PBS and then re-suspended in buffer M (5 mM 
Hepes, pH 7.4, 250 mM mannitol, 0.5 mM EGTA, 0.1% BSA), 
supplemented with protease inhibitors, and homogenized. The 
homogenate was centrifuged at 800 g for 10 min at 4 °C and the 
supernatant was then centrifuged at 12,000 g for 30 min at 4 °C. The 
resulting supernatant represented the cytosolic fraction, whereas the pellet 
constituting the mitochondrial fraction was resuspended in RIPA buffer.  
To obtain nuclear and cytosolic extracts, cells plated at a density of 2 x 
10
6
 cells/plate (143 cm
2
) were harvested and washed with PBS. Cells 
were resuspended with lysis buffer (10 mM Tris HCl, pH 7.5, 2 mM 
MgCl2, 3 mM CaCl2, 0.3 M sucrose), supplemented with 1 mM DTT and 
protease inhibitors, and homogenized. The homogenate was centrifuged 
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at 10,000 g for 20 min at 4 °C and the supernatant (cytosolic fraction) 
transferred in a clean tube. Then, the nuclei pellet was resuspended in 
extraction buffer (20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 0.42 M NaCl, 
0.2 mM EDTA, 25% (v/v) glycerol), supplemented with 1 mM DTT and 
protease inhibitors, shaken gently for 30 min at 4 °C and centrifuged at 
20,000 g for 5 min at 4 °C. The resulting supernatant represented the 
nuclear fraction. Equal amounts of total, cytosolic, mitochondrial, and 
nuclear protein extract were used for Western blot analysis. Briefly, 
protein samples were dissolved in SDS/reducing loading buffer, run on a 
12% SDS-PAGE, then transferred to Immobilon P membrane (Millipore, 
Vimodrone MI, Italy). The filter was incubated with the specific primary 
antibody at 4 °C overnight and with the horseradish peroxidase-linked 
secondary antibody at room temperature for 1 hour. Membranes were 
then analyzed by an enhanced chemiluminescence reaction, using Super 
SignalWest Pico kit (Pierce - Thermo Scientific, Rockford, IL USA) 
according to the manufacturer’s instructions; signals were visualized by 
autoradiography. 
 
 
2.12 Immunofluorescence and confocal microscopy 
Cells were plated on coverslips at a density of 0.3 x 10
6
 cells/well in 
6-well plates. At the end of the treatment for 24h, cells were incubated 
with 90 nM MitoTracker Red (Invitrogen) at 37 °C for 1 hour and then 
washed three times with ice-cold PBS. The cells were fixed with 4% 
paraformaldehyde, permeabilized with 0.1% Triton X-100 and blocked in 
donkey serum (Millipore) diluted 1:10 in PBS, for 60 min at room 
temperature. Coverslips were incubated for 1 hour at 37 °C with a 
primary rabbit polyclonal antibody against AIF, diluted 1:50 in PBS, and 
subsequently incubated for 1 hour at 37 °C with a FITC donkey anti-
rabbit secondary antibody (Jackson ImmunoResearch Europe Ltd.), 
diluted 1:100 in PBS. At the end, nuclei were labelled with 4',6-
diamidino-2-phenylindole (DAPI) for 15 min at room temperature. Slide 
mounting was done in Vectashield (Burlingame, CA, USA). Fluorescent-
labeled cells were viewed with a confocal laser scanner microscope (Zeiss 
LSM 700, Jena, Germany) and the objective used was EC Plan-neofluar 
40X/1.30 oil. The laser line was set at 488 nm for the FITC-conjugated 
antibody, at 555 nm for MitoTracker Red and 405 nm for DAPI. Images 
were acquired simultaneously in the green, red and blue channels, and as 
z-stack. Pictures were processed using ImageJ software (NIH, USA) to 
reconstruct x-axis projection using stack images. 
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2.13 Free sterol and sterol-derived compound analysis 
Cells were plated at a density of 1 x 10
6
 cells/plate (75 cm
2
). 
Control cells, 7-DHC-treated cells (38.5 μg/mL), and respective culture 
media, were harvested protecting them from direct light. The cells were 
washed with PBS to eliminate traces of medium. To avoid sterol 
oxidation, BHT was suddenly added to cell and medium samples to 
provide a final concentration of 3 g/L. The cells were disrupted with 
mechanical techniques (freezing-defrosting, sonicating), and 
homogenized using a mini-potter on ice; the protein concentration in cell 
homogenates was determined by the method of Bradford [35].  
7-DHC and cholesterol analysis was performed using 20 μL of vehicle 
suspension or 200 μL of medium or 100 μL of cell homogenate samples 
mixed with 25 μL of internal standard, 1 mL of ethanol containing 3 g/L 
BHT, and 1 mL of distilled water; the solution was extracted with hexane 
(3 x 2 mL). The upper organic phases were pooled and evaporated under 
a gentle stream of nitrogen. The dry residue was reconstituted with 50 L 
of dichloromethane, and 1 L of the resulting solution was injected into 
the GC-FID.  
The extraction of oxidized sterol compounds, after hydrolysis, was 
performed according to Pulfer and Murphy procedure [36]. One-hundred 
μL of medium or cell homogenate samples were mixed with 25 μL of IS 
and hydrolyzed for 60 min at 80 °C in 2 mL of 1N KOH in 90% methanol 
containing 3 g/L BHT. After the hydrolysis, the sample was diluted with 
2 mL of distilled water, and extracted with dichloromethane (3 mL 
followed by 2 mL two times). The lower phases were pooled and 
evaporated under a gentle stream of nitrogen. The dry residue was 
derivatized by the addition of 30 L pyridine and 70 L BSTFA followed 
by a heating at 80 °C for 30 min. The derivatized sample was dried under 
nitrogen stream and the residue was dissolved with 50 L 
dichloromethane; 1 L of the solution was injected into the GC-FID and 
GC-MS. 
 
 
2.14 Gas chromatography (GC-FID and GC-MS) 
Free sterol analysis was performed as previously described [9]. 
Briefly, a gas chromatograph equipped with a flame ionization detector 
(GC-FID, HP-5890, Agilent Laboratories, CA, USA) equipped with a 
SAC-5 capillary column (30 m length, 0.25 mm I.D., 0.25 m film 
thickness; Supelco, Germany), was used to separate the sterols using 
nitrogen as carrier gas. The linear velocity of carrier gas was 45 cm/s. 
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Injector and detector temperatures were fixed at 300 °C, and the oven 
temperature at 290 °C for a total run time of 30 min. Sterol concentrations 
were obtained by interpolating the peak area ratios (analyte/IS) on the 
calibration curves. The sterol-derived compounds were analyzed by GC-
FID (HP-5890) and by GC-MS controlled by a work station using 
MassLab 3.4 as software (Fisons, model GC 8000/MD800). 
Chromatography conditions of GC-MS apparatus were as above 
described and using helium carrier gas. Qualitative analysis was 
performed by GC-MS scanning the mass range from m/z 50 to 600 
comparing compound mass spectra with those reported into mass spectra 
libraries (Wiley and National Institute of Standards and Technology). 
Quantitative analysis was performed using GC-FID, compound 
identification was obtained by the relative retention time (Rf=Rt 
analite/Rt IS). Oxidized sterol compound concentrations were calculated 
from the ratio of peak area compared to calibration curves of oxysterols 
(cholesterol 5β,6β-epoxide, 25-hydroxy-cholesterol, and 7-keto-
cholesterol). 
 
 
2.15 Liquid chromatography tandem mass spectrometry (LC-MS/MS) 
The oxidized sterol compounds were also analyzed by LC-MS/MS 
using a slight modification of the method of Pulfer and Murphy [36]. 
Briefly, the dried extracts were dissolved in 200 l ethanol, then 5 l 
were injected onto a reverse phase column (Zorbax Eclipse® Plus C18, 
3.5 m, 150 x 2.1 mm; Agilent Technologies, Cernusco, Italia) at a flow 
rate of 0.3 mL/min. Solvent A was methanol/water/acetonitrile (v/v/v, 
60:20:20) with 4 mM ammonium acetate; solvent B was methanol with 4 
mM ammonium acetate. The gradient ran from 90 to 100% solvent B in 
10 min and stayed at 100% solvent B for 10 min. Multiple reaction 
monitoring analysis was carried out on a Quattro-Micro mass 
spectrometer (Waters Corporation, Milford, USA). The mass 
spectrometer operated in positive ion mode by atmospheric pressure 
chemical ionization probe (APCI). The cone voltage was set at 25 V, the 
collision energy at 20 eV and the gas cell Pirani gauge at 2.2 x 10-3 mbar 
using argon as the collision gas. Source temperature, desolvation gas flow 
rate, desolvation gas temperature, cone gas flow rate and gas nebulizer 
pressure were set at 120 °C, 350 L/h, 350 °C, 50 L/h and 80 psi, 
respectively, while the corona discharge was set at 2 mA. Multiple 
reaction monitoring (MRM) transitions were m/z 385 > 367 for 7-DHC, 
25-hydroxy-cholesterol, and 5β,6β-epoxide, m/z 399 > 381 for 3β,5-
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dihydroxycholest-7-en-6-one (DHCEO) and 7-keto-dehydro-cholesterol 
(7-keto-DHC), and m/z 401 > 383 for 25-hydroxy-7-DHC and 7-keto-
cholesterol. The dwell time for each transition was 100 ms. Quantitative 
analysis was carried out using calibration curves of 25-hydroxy-
cholesterol for 25-hydroxy-7-DHC, and of 7-keto-cholesterol for DHCEO 
and 7-keto-DHC. 
 
 
2.16 Statistical analysis 
Data are reported as average, standard deviation, and standard error. 
The statistical significance of differences among groups was evaluated 
using the ANOVA, with the Bonferroni correction as post-hoc test, or the 
Student’s t-test where appropriate. The significance was accepted at the 
level of p < 0.05. 
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3. Results 
 
3.1 Study on 7-DHC stability 
In order to evaluate the 7-DHC stability, we monitored the 7-DHC 
concentration in the suspension of NaUDC/7-DHC used to prepare 7-
DHC-enriched media. The suspension was stored at 4°C up to three 
months. The average concentration of 7-DHC suddenly after the 
preparation of the suspension was 3.97 ± 0.01 g/L. As shown in figure 1, 
no significant changes from baseline values were observed in the 7-DHC 
levels in the suspension up to 90 days of storage at 4 °C. 
 
 
   
 
Fig. 1 Time-course of 7-DHC level in the NaUDC/7-DHC suspension   
7-DHC concentrations were determined by GC-FID method and were expressed 
as percentage of average baseline values (3.97 g/L). Data from quadruplicate 
experiments are reported as mean ± SE.  
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3.2 Sterol levels in culture media and melanoma cells 
It is known that handling of 7-DHC in culture media may lead to its 
disruption/conversion into derivative compounds [12]. Therefore, in order 
to assess the correlation between the levels of 7-DHC and its effects on 
melanoma cells, we monitored by GC-FID the levels of cholesterol and 7-
DHC in culture media and cells of experiments carried out in this work. 
The quantitative analysis of free sterols was made at baseline and during 
the time-course of stimulation. The levels of cholesterol in the culture 
media from 7-DHC-treated melanoma cells were almost unchanged 
during the first 12 hours, then the levels decreased progressively up to 
67% after 72 hours (Table 1).  
 
 
 
Table 1.  Cholesterol levels in 7-DHC-treated and untreated cells and media 
The micromoles of cholesterol can be obtained dividing the values by the molecular weight of 
386.6 Da. * Statistical significance. 
 
 
 
A similar behavior was essentially observed in media from untreated 
cells. On the other hand, cholesterol levels in untreated or treated 
melanoma cells were stable during the whole incubation time, 
independently of some differences observed in the basal levels of this 
sterol measured between untreated and treated cells. However, these 
variations were significant only at the incubation times of 12 and 24 hours 
(Table 1). Concerning the levels of 7-DHC, the corresponding values 
measured in media and cells are shown in Table 2.  
 
 
 
 basal 12h 24h 48h 72h 
CHOL in cells µg/mg of proteins (SE) 
Treated 24.2 (2.4) 35.0 (1.8) 34.2 (1.9) 29.7 (2.7) 37.4 (4.7) 
Untreated 24.2 (2.4) 28.0 (1.2) 24.2 (1.7) 25.7 (0.1) 26.4 (5.2) 
*p  0.03 0.01 0.34 0.22 
CHOL in media µg/mL (SE) 
Treated 8.2 (0.4) 8.0 (0.1) 7.2 (0.5) 5.9 (0.6) 5.5 (0.8) 
Untreated 8.0 (0.1) 8.2 (0.2) 8.5 (0.3) 5.2 (0.7) 5.4 (1.4) 
*p 0.76 0.44 0.12 0.49 0.96 
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Table 2. Total amounts and percentages of 7-DHC in treated cells and media 
a: Total micrograms (standard error) of 7-DHC in media and cells as averages/well.  
: 7-DHC gap as: (7-DHC basal in media) - (7-DHC in media + 7-DHC in cells).  
The micromoles of 7-DHC can be calculated dividing the values by 384.6 Da (molecular weight). 
 
 
 
The comparison of these data suggests that 7-DHC moved from media to 
cells and that, after 12 hours of treatment, a great percentage of this sterol 
(82%) already entered the cell; the influx reached 86% after 72 hours.  
However, as reported in Table 2, a gap of 7-DHC was observed between 
total amount at basal state in the culture media and the sum of 7-DHC 
found in media and treated cells at different incubation times. This gap 
ranged between 4.1% and 6.9% during the whole incubation time. These 
results could indicate the presence of other sterol compounds, which were 
determined both by GC-MS and LC-MS/MS. At basal state the medium 
enriched with 7-DHC contained 5.67 g/well of cholesta-4,6,8(14)-trien-
3ol, 5.44 g/well of cholesta-5,7,9(11)-trien-3ol, and 1.80 g/well of 
cholesta-5,8,24-trien-3ol. During the time-course of treatment these 
compounds entered rapidly the cells reaching on average a percentage of 
44%, 72%, and 83%, respectively. In addition, a new metabolite was 
found into the cells. This compound, identified as 25-hydroxy-7-DHC, 
was undetectable in media and its quantity ranged between 2.90 and 5.26 
μg/well (Table 3). As reported in Table 4, the analysis performed by LC-
MS/MS confirmed this result, and showed that the medium enriched with 
7-DHC, at basal state, contained on average 3.06 g/well of 7-keto-
cholesterol, 0.68 g/well of DHCEO, and 0.11 g/well of 7-keto-DHC. 
After 72 hours of treatment with 7-DHC, the cells contained these 
compounds in part as influx from the medium and in part as metabolites 
produced from cholesterol and 7-DHC. Since the amount of each 
compound in the medium was on average always less than 1 g/mL (8 
mL/well), this concentration was not considered toxic for cell growth.
 basal 12h 24h 48h 72h 
7-DHC   µg (SE)
a
   
Media 272.4 (20.2) 37.8 (0.9) 36.0 (4.2) 17.2 (7.4) 18.9 (9.0) 
Cells - 223.3 (2.0) 224.8 (6.2) 230.3 (15.1) 234.7 (14.5) 
   Average %   
Media 100 13.9 13.2 6.3 6.9 
Cells - 82.0 82.5 84.6 86.2 
 - 4.1 5.4 6.4 6.9 
  
 
 
 
 
 
Table 3.  Levels of sterol-derived compounds in 7-DHC-treated cells and media analyzed by GC-FID and GC-MS 
 
a: Total micrograms (standard error) of each sterol-derived compound in media and cells as average/well (n=3). The micromoles of compounds can be 
obtained dividing the values by the following molecular weights (Da): 382.6 for Cholesta-4,6,8(14)-trien-3-ol, Cholesta-5,7,9(11)-trien-3-ol, and Cholesta-
5,7,24-trien-3-ol; and 400.6 for 25-hydroxy-7-DHC. 
 
 
 
 Cholesta-4,6,8(14)-trien-3-ol Cholesta-5,7,9(11)-trien-3-ol Cholesta-5,7,24-trien-3-ol 25-hydroxy-7-DHC 
    µg (SE)
a
     
Incubation 
times 
Media Cells Media Cells Media Cells Media Cells 
basal 5.67 (0.51) - 5.44 (0.24) - 1.80 (0.08) - - - 
12 hours 1.76 (0.37) 2.31 (0.25) 1.75 (0.51) 3.15 (0.13) - 1.16 (0.04) - 5.26 (0.11) 
24 hours 2.10 (0.27) 2.48 (0.27) 1.86 (0.20) 3.57 (0.01) - 1.34 (0.09) - 2.90 (0.03) 
48 hours 1.10 (0.08) 2.39 (0.25) 2.34 (0.16) 3.08 (0.19) - 1.45 (0.03) - 4.40 (1.00) 
72 hours 0.77 (0.02) 2.49 (0.21) 1.58 (0.02) 3.91 (0.14) - 1.49 (0.26) - 4.86 (1.13) 
16 
  
 
 
 
 
 
 
 
Table 4.  Levels of sterol-derived compounds in 7-DHC-treated cells and media analyzed by LC-MS/MS 
 
a = Total micrograms (standard error) of each sterol-derived compound in cells and media as average/well (n=3). The micromoles of compounds can be 
obtained dividing the values by the following molecular weights (Da): 400.6 for 25-hydroxy-7-DHC and 7-keto-cholesterol, 416.6 for DHCEO, and 398.6 
for 7-keto-DHC. 
 
 
 
 25-hydroxy-7-DHC 7-keto-cholesterol DHCEO 7-keto-DHC 
Incubation times µg (SE)
a
 
7-DHC-Treated Media Cells Media Cells Media Cells Media Cells 
basal - - 3.06 (0.28) 0.13 (0.01) 0.68 (0.03) - 0.11 (0.01) - 
72 hours - 4.42 (0.99) 0.90 (0.08) 0.48 (0.04) 0.56 (0.04) 0.76 (0.02) 0.16 (0.01) 0.04 (0.01) 
Untreated         
basal - - 4.89 (0.44) 0.13 (0.01) - - - - 
72 hours - - 4.65 (0.39) 0.16 (0.01) - - - - 
17 
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3.3 Cytotoxic effect of 7-DHC in melanoma cell lines 
To investigate if the treatment of A2058 melanoma cells with 7-
DHC affects cell viability, a MTT assay was performed. To this aim, 
melanoma cells were incubated for 24 and 48 hours with two different 
concentrations of 7-DHC (19.2 or 38.5 µg/mL) or with the vehicle alone. 
The spectrophotometric analysis showed a decrease of cell proliferation 
after 24 hours only in the presence of 38.5 µg/mL 7-DHC, whereas after 
48 hours of incubation with 7-DHC, a dose-dependent decrease of cell 
growth was observed (Fig. 2). 
 
 
Fig. 2 Effect of 7-DHC on cell viability of A2058 melanoma cells 
A2058 cells were incubated for 24 and 48 hours with vehicle alone 
(white bars), 19.2 µg/mL (grey bars) or 38.5 g/mL (black bars) 7-
DHC. Cell viability was evaluated by MTT assay and was reported 
as arbitrary units (a.u.). Data from triplicate experiments are 
reported as mean ± SD. *p < 0.05 and **p < 0.01 compared to 
untreated cells.  
 
 
 
These results suggest that the treatment of A2058 cells with 7-DHC could 
exert a cytotoxic effect on this melanoma cell line. In addition, the 
cytotoxic effect of 7-DHC has been also confirmed on SAN melanoma 
cells and the results were comparable to that obtained on A2058 cell line 
(Fig. 3). 
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                         Fig. 3 Effect of 7-DHC on cell viability of SAN melanoma cells 
SAN cells were incubated for 24 and 48 hours with vehicle alone 
(white bars), 19.2 µg/mL (grey bars) or 38.5 µg/mL (black bars) 7-
DHC. Cell viability was evaluated by MTT assay and was reported as 
arbitrary units (a.u.). Data from triplicate experiments are reported as 
mean ± SD. *p < 0.05 and *p < 0.01 compared to untreated cells. 
 
 
We have evaluated if the reduction of cell proliferation induced by the 7-
DHC treatment of A2058 cells could be indicative of a cell death process. 
It is known that LDH activity significantly increases in culture media of 
cells undergoing a necrosis. Therefore, we have assayed the LDH activity 
in culture media from A2058 cells incubated up to 48 hours with 38.5 
µg/mL of 7-DHC. However, the results showed a not significant release 
of LDH from A2058 cells treated with 7-DHC compared to untreated 
cells (Table 5).  
 
 
Table 5.  LDH activity in untreated and 7-DHC-treated A2058 culture media 
Differences among groups were not statistically significant (ANOVA).   
 Untreated 7-DHC-treated  
  19.2 mg/mL 38.5 mg/mL 
Incubation times IU/L (SE) 
24 hours 78 (1.5) 76 (2.0) 75 (2.8) 
48 hours 93 (0.3) 95 (2.0) 98 (1.2) 
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Then, we analyzed the exposure of phosphatidylserine moieties on cell 
membranes, identified by Annexin V binding, after cell treatment with 7-
DHC. As shown in Fig. 4a the treatment of A2058 cells with 19.2 or 38.5 
µg/mL 7-DHC for 24 hours induced a significant increase of the 
percentage of early apoptotic cells (Annexin+/PI−), whereas the increase 
of percentage of late apoptotic cells (Annexin+/PI+) was low even if 
significant after treatment with 19.2 µg/mL 7-DHC. 
 
 
 
 
Fig. 4 Pro-apoptotic effect of 7-DHC on A2058 melanoma cells 
a) A2058 cells were incubated for 24 hours with vehicle alone (white bars), 19.2 µg/mL (grey bars) 
or 38.5 g/mL (black bars). Annexin V-FITC binding and the propidium iodide incorporation were 
evaluated cytofluorimetrically. Annexin V-positive/PI negative cells (AV+/PI-) and Annexin V-
positive/PI positive cells (AV+/PI+) represent early and late apoptotic cells, respectively. The data 
were expressed as percentage. b) A2058 cells were incubated for 48 and 72 hours with vehicle 
alone (white bars), 19.2 µg/mL (grey bars) or 38.5 g/mL (black bars) 7-DHC. PI staining and 
cytofluorimetric analysis were used to evaluate the number of nuclei with a hypodiploid content of 
DNA and the data were expressed as percentage. Data from triplicate experiments are reported as 
mean ± SD. *p < 0.05 and **p < 0.01 compared to untreated cells. 
 
 
 
Furthermore, flow cytometric analysis of PI incorporation on A2058 
cells, incubated with 19.2 or 38.5 µg/mL 7-DHC for different times, 
showed that the number of nuclei with sub-diploid DNA content started 
to increase after 48 hours of treatment compared to untreated cells, and 
after 72 hours a dose-dependent effect was evident (Fig. 4b). The same 
effect was observed on SAN melanoma cells after 48 hours of treatment 
with 38.5 µg/mL of 7-DHC (Fig. 5). 
  
 
b 
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Fig. 5 Pro-apoptotic effect of 7-DHC on SAN melanoma cells 
SAN cells were incubated for 48 hours with vehicle alone (white bars) 
or 38.5 g/mL (black bars) 7-DHC. PI staining and cytofluorimetric 
analysis were used to evaluate the number of nuclei with a 
hypodiploid content of DNA and the data were expressed as 
percentage. Data from triplicate experiments are reported as mean ± 
SD. **p < 0.01 compared to untreated cells. 
 
 
 
 
These data are indicative that the effect of 7-DHC may be mainly due to 
an apoptotic process.  
As activation of caspase is one of the widely recognized features of 
apoptosis [37], the enzymatic activity of caspase-3 was measured after 7-
DHC treatment. However, A2058 cells, incubated with 19.2 or 38.5 
µg/mL 7-DHC for different times, didn’t show any significant variation 
of caspase-3 activity. 
Furthermore, since caspase-3 mediates the cleavage of PARP-1, we 
evaluated the inactivation of PARP-1 analyzing in nuclear and cytosolic 
fractions both 116 kDa and 89 kDa forms, which represent the uncleaved 
and cleaved form of PARP-1, respectively. Western blot analysis showed 
the presence of PARP-1 as intact protein in nuclear fraction (116 kDa), 
while PARP-1 cleaved fragment (89 kDa) was not detected in both 
nuclear and cytosolic extracts (Fig. 6). Hence, these data are indicative 
that the 7-DHC affects the viability of the A2058 likely in a caspase-
independent manner. 
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Fig. 6 Effect of 7-DHC on PARP-1 protein levels in nuclear and 
cytosolic fractions  
A2058 cells were incubated for 24 hours with vehicle alone or 38.5 g/mL 
7-DHC. a) Nuclear and cytosolic protein extracts were used to perform 
PARP-1 Western blot analysis. Histone H3 and -tubulin were utilized to 
evaluate the loading and purity of nuclear and cytosolic protein fractions, 
respectively. b) Densitometric analysis of PARP-1 protein levels in nuclear 
fraction. Data from triplicate experiments are reported as mean ± SD. 
 
 
3.4 Effect of 7-DHC on the intracellular ROS and glutathione levels 
Structure of 7-DHC is very similar to that of cholesterol, but 7-
DHC is a molecule more reactive because of the presence in its structure 
of a conjugated double bound. Hence, high 7-DHC intracellular levels can 
affect the cellular physiology and in particular the intracellular redox 
state. In fact, 7-DHC may contribute to this process by replacing 
cholesterol in cell compartments and then altering signal transduction 
processes in lipid rafts generating oxidized 7-DHC derivatives [38].  
To this aim, the intracellular ROS level was measured in A2058 cells 
treated with 7-DHC. In particular, the cells were incubated with 38.5 
µg/mL of 7-DHC, and ROS production was detected at different times 
through the use of the fluorescent probe DCFH-DA (Fig. 7a). An 
increment of fluorescence intensity was clearly evident already after 2 
hours of incubation; this increase remained up to 8 hours of 7-DHC 
treatment. Furthermore, ROS production induced by 7-DHC was also 
evaluated on cells pre-treated with NAC (10 mM) as antioxidant or 
apocynin (0.5 mM) as NADPH oxidase inhibitor. After 2 hours of 
treatment with 7-DHC, the pre-treatment with NAC or apocynin 
antagonized the 7-DHC effect and the ROS levels were unchanged 
respect to basal state (Fig. 7b).  
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          Fig. 7 Effect of 7-DHC on the intracellular ROS and glutathione levels 
A2058 cells were incubated for the indicated time periods with vehicle alone (white 
bars) or 38.5 g/mL 7-DHC (black bars). The fluorescent probe DCFH-DA was used 
to detect the intracellular ROS levels. Fluorescence intensity was reported as arbitrary 
units (a.u.) (panel a). A2058 cells were pre-incubated with the free radical scavenger, 
NAC (10 mM), or apocynin (0.5 mM), a NADPH oxidase inhibitor. The intracellular 
ROS level was evaluated after 2 hours of 7-DHC treatment by using the fluorescent 
probe DCFH-DA. ROS production was expressed as percentage of control (panel b). 
The intracellular GSH level and the GSH/GSSG ratio were evaluated after 2 hours of 
7-DHC treatment. The data were expressed as percentage of control (panel c).  Data 
from triplicate experiments are reported as mean ± SD. *p < 0.05 and **p < 0.01 
compared to untreated cells. 
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These results suggest that 7-DHC alters the intracellular redox state and, 
in particular, the increase of ROS levels is mediated by NADPH oxidase.  
In addition, to further evaluate the alteration of redox state by 7-DHC we 
measured the intracellular levels of GSH and GSH/GSSG ratio.  
The results reported in Fig. 7c show that both GSH level and GSH/GSSG 
ratio were statistically reduced after 2 hours of 7-DHC treatment.  
 
 
3.5 Effect of NAC and apocynin on apoptosis induced by 7-DHC 
The alteration of redox state of melanoma cells induced by 7-DHC 
may represent an early event that can contribute to affect the cell viability. 
Therefore, we investigated if the apoptotic effect of 7-DHC is 
antagonized by NAC (10 mM) or apocynin (0.5 mM) pre-treatment. As 
reported in Fig. 8, the pro-apoptotic effect on A2058 cells treated for 72 
hours with 38.5 µg/mL 7-DHC was partially but significantly reduced by 
both NAC and apocynin pre-treatment, even though the percentage of 
apoptosis observed in NAC and apocynin pre-treated cells was still and 
significantly higher compared to untreated control cells.  
 
 
 
 
Fig. 8 Effect of NAC and apocynin on 7-DHC induced apoptosis  
The apoptotic effect of 7-DHC was evaluated on A2058 cells pre-incubated 
with NAC (10 mM) or apocynin (0.5 mM) before the treatment with vehicle 
alone or with 38.5 g/mL 7-DHC for 72 hours. Apoptosis was revealed by 
cytofluorimetric analysis and was expressed as percentage. Data from 
triplicate experiments are reported as mean ± SD. *p < 0.05 and **p < 0.01 
compared to untreated cells. 
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3.6 Effect of 7-DHC on mitochondrial membrane potential 
The mitochondria respiratory chain is the major source of cellular 
ROS; at the same time, mitochondria are also the main targets of ROS 
detrimental effects. Indeed, the increase of intracellular ROS levels 
represents one among the critical events that alter the mitochondrial 
membrane potential, thus contributing to trigger mitochondria 
dysfunction. Therefore, the effect of 7-DHC treatment on mitochondrial 
membrane potential of A2058 cells was evaluated by measuring the 
incorporation of the fluorescent probe R123. This compound crosses the 
mitochondrial membrane and accumulates into the matrix only when the 
trans-membrane potential is preserved; therefore, in case of a loss of the 
membrane potential, the R123 fluorescence undergoes a significant 
reduction [39]. Data reported in Fig. 9 indicated that the reduction of 
R123 mitochondrial incorporation in 7-DHC-treated cells was statistically 
significant compared to untreated cells. In fact, a decrease of 
mitochondrial membrane potential was detected in A2058 cells incubated 
for 24 and 48 hours with 38.5 µg/mL 7-DHC. 
 
 
Fig. 9 Mitochondrial membrane depolarization induced by 7-DHC 
A2058 cells were incubated for 24 and 48 hours with vehicle alone 
(white bars) or 38.5 g/mL 7-DHC (black bars). The fluorescent probe 
R123 was used to evaluate the mitochondrial membrane potential. 
Fluorescence intensity was reported as arbitrary units (a.u.). Data from 
triplicate experiments are reported as mean ± SD. *p < 0.05 compared to 
untreated cells. 
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3.7 Effect of 7-DHC on levels and subcellular localization of some 
proteins involved in the apoptotic process  
To obtain further insights on the molecular mechanisms activated 
by 7-DHC during cellular treatment, we have analyzed the levels of some 
proteins that regulate the apoptotic process. Proteins of Bcl-2 family play 
a key role in the intrinsic apoptotic process [40,41]; therefore, we have 
evaluated the protein levels of Bcl-2 and Bax, as well as the ratio Bcl-
2/Bax, because Bcl-2 and Bax are considered typical anti-apoptotic and 
pro-apoptotic factors, respectively. As shown in Fig. 10a,b,c, the levels of 
Bcl-2 in total protein extract were unchanged in A2058 cells treated for 
24 hours with 38.5 µg/mL 7-DHC, whereas the increased levels of Bax 
and the reduction of Bcl-2/Bax ratio were statistically significant in 
treated cells compared to untreated cells. In particular, as shown in Fig. 
10d, in subcellular fractions of A2058 treated cells with 38.5 µg/mL 7-
DHC for 24 hours, both cytosolic and mitochondrial levels of Bax were 
increased compared to untreated cells. 
        
Fig. 10 Effect of 7-DHC on Bcl-2 and Bax intracellular protein levels 
A2058 cells were incubated for 24 hours with vehicle alone or 38.5 g/mL 7-DHC. a) 
Total proteins extracts were used to perform Western blot experiments. -actin and 
GAPDH were utilized as loading control for Bcl-2 and Bax protein levels evaluation, 
respectively. b) Densitometric analysis of Bcl-2 and Bax protein levels. c) 
Determination of Bcl-2/Bax ratio.d) Bax protein levels in cytosolic and mitochondrial 
fractions. Mitochondrial marker COX-IV and the cytosolic marker β-actin were used 
to verify the purity of fractions as well as loading controls. Data from triplicate 
experiments are reported as mean ± SD. **p < 0.01 compared to untreated cells. 
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As 7-DHC treatment on A2058 cells did not have any effect on caspase-3 
activation, we have analyzed the protein levels of AIF, a main mediator of 
caspase-independent cell death [42]. A2058 cells incubated with 38.5 
µg/mL 7-DHC for 24 hours showed a statistically significant increase of 
AIF protein levels (Fig. 11). Furthermore, to verify the subcellular 
localization of AIF we performed immunofluorescence experiments by 
confocal microscopy. As showed in fig 12, AIF immunostaining is more 
evident in treated A2058 cells (panels d,e,f) compared to control cells 
(panels a,b,c). Furthermore, as better showed in 3D image of treated cells 
(panel e) and untreated cells (panel b), immunofluorescence analysis 
detected a nuclear AIF immunoreactivity only in the treated cells. These 
results support the hypothesis that cell death induced by 7-DHC may be 
mainly due to an apoptotic process caspase-independent. 
 
 
 
 
Fig. 11 Effect of 7-DHC on AIF intracellular protein levels 
A2058 cells were incubated for 24 hours with vehicle alone or 
38.5 g/mL 7-DHC. a) Western blot analysis of AIF levels 
was performed on total protein extracts; GAPDH was used as 
loading control for protein levels evaluation. b) Densitometric 
analysis of AIF protein levels. Data from three independent 
experiments are reported as mean ± SD. *p < 0.05 compared 
to untreated cells. 
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Fig. 12 Effect of 7-DHC on AIF subcellular localization  
A2058 cells were treated for 24 hours with vehicle alone (a, b, c) or 38.5 g/mL 7-DHC (d, 
e, f). Nuclei staining (blue fluorescence) was performed with 4', 6-diamidino-2-
phenylindole (DAPI); mitochondria were stained with MitoTracker Red (red fluorescence); 
AIF immunostaining (green fluorescence) was performed using a monoclonal anti-AIF 
antibody, followed by FITC-conjugated antibody. The signals are showed as a merge (a and 
d), the cells in the inset are represented as x-axis volume projection (b and e), and as 
splitted channels (c and f). The shown results are representative of three independent 
immunofluorescence experiments. 
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4. Discussion and Conclusions 
 
The skin plays a pivotal role to maintain the body homeostasis and 
contributes also to immune and neuroendocrine activities [20]. The 
exposure of skin to solar radiations (e.g. UV-A and -B) causes skin 
damage including oxidative stress, DNA damage, inflammation, 
melanoma, and non-melanoma skin cancer. The results presented here 
show that the 7-DHC, a lipophilic compound, affects the growth of 
A2058 melanoma cells in vitro at concentrations ranging from 19.2 to 
38.5 g/mL. The 7-DHC, or pro-vitamin D, is naturally present at 
physiological levels in the skin and, under UV exposure, it serves as the 
precursor for active metabolites that influence the formation and 
maintenance of barrier function and other activities such as anti-
microbial, anti-senescence, and photoprotective of skin. In this work 
A2058 melanoma cells were treated with 7-DHC, in dark conditions, to 
assess its direct effect on vitality of this cancerous cell line.  
In fact, the most of published work have tested the derivative products of 
7-DHC induced by UV in cell models to assess the effects in 
keratinocyte, in which 7-DHC enhances UV-induced oxidative stress 
leading to inflammation producing more ROS, and cell death by a ROS 
and caspase-3 dependent apoptotic mechanism [10,26]. On the other 
hand, in keratinocytes, UV-B irradiation induces non-enzymatic 
isomerization of 7-DHC converting biologically inactive vitamin D3 to 
the hormone calcitriol (1,25-dihydroxyvitamin D3) and to other vitamin 
D analogs. These compounds have antiproliferative and pro-
differentiative effects on epidermal keratinocytes and have become potent 
therapeutic agents for the treatment of proliferative skin disorders [43] 
and malignant melanoma [44]. Instead, studies in which the 7-DHC has 
been directly used to evaluate its effects in cancer cells are lacking. 
In this work we addressed the cellular mechanisms for responses, in vitro, 
of melanoma cells to 7-DHC to elucidate its cytotoxic and pro-apoptotic 
effects. We chose A2058 cells, a highly metastatic human amelanotic cell 
line, to examine the cytotoxicity of this lipophilic metabolite of 
cholesterol and vitamin D biosynthesis. 7-DHC levels used to stimulate 
melanoma cells mimicked those found in the blood of SLOS patients with 
low/mild increase of 7-DHC levels and 7-DHC/cholesterol ratio. It is 
known that 7-DHC is prone to oxidation and has a high oxidizing power 
[18,19]; therefore, in order to understand its direct effects and to reduce 
the formation of oxidized compounds we prepared a suspension using the 
NaUDC as vehicle to transfer the 7-DHC from the culture medium into 
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the cells. In fact, the suspension of NaUDC/7-DHC showed a higher 
stability of the compound during the storage at 4 °C up to three months 
(Fig. 1), even if its preparation was more laborious than other procedures. 
We evaluated the cytotoxic potential of 7-DHC on A2058 melanoma cell 
line, as well as on SAN cell line, by monitoring the cell proliferating rate 
through the MTT assay. The data from these experiments indicated a 
decrease of cell proliferation after 24 hours in the presence of 38.5 µg/mL 
7-DHC and after 48 hours of incubation with 7-DHC a dose-dependent 
decrease of cell viability was observed (Fig. 2,3). These results suggest 
that the treatment of cells with 7-DHC reduces the viability of these 
melanoma cell lines.  
During the monitoring of lipids extracted from treated melanoma cells 
and culture media, we found that more than 82% of 7-DHC entered the 
cells already after 12 hours; this high percentage of 7-DHC persisted even 
after 72 hours, reaching the value of 86%. On the other hand, the amount 
of 7-DHC transformed into other derivative compounds ranged from 4 to 
7%. To note that a small proportion of 7-DHC could be lost during the 
various steps of the procedure either for the contact with the glass and 
with the plastic of the containers used in the experiments. In addition, 
care was taken during the manipulation of cell cultures to reduce the 
effects of light radiations on 7-DHC. Nevertheless, we have measured the 
levels of the compounds derived from cholesterol and 7-DHC, and we 
found that at basal state the culture medium enriched with 7-DHC (38.5 
g/mL) already contained mainly three sterol derivatives (cholesta-
4,6,8(14)-trien-3ol, cholesta-5,7,9(11)-trien-3ol, cholesta-5,8,24-trien-3ol) 
whose sum was on average accounted for 13 g/well (less than 2 g/mL). 
These compounds have been already described in the literature as 
derivatives of non-enzymatic transformation of 7-DHC. As described for 
7-DHC, also these derivative compounds entered rapidly the cells. In 
addition, from GC-FID and GC-MS analyses of A2058 melanoma cell 
extracts we found a new metabolite, undetectable in media, identified as 
25-hydroxy-7-DHC; this result was also confirmed by LC-MS/MS (Tab. 
3, and Tab. 4). Moreover, at basal state, the medium enriched with 7-
DHC (38.5 μg/mL) contained small amounts of 7-keto-cholesterol, 7-
keto-DHC, and DHCEO, even though their total amount was less than 1 
g/mL (Tab. 4). However, the concentration of these compounds, found 
in 7-DHC treated cells, is likely too low to be considered toxic for cell 
growth [28]. Therefore, it is possible to hypothesize that 7-DHC as such, 
and not its oxidized derivatives, is responsible for the reduced cell 
proliferation observed during the treatment of melanoma cells. Hence, it 
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was interesting to investigate if the reduction of the cell proliferation of 
A2058 cells measured during 7-DHC treatment was indicative of a cell 
death process. The LDH activity assayed in the culture media of A2058 
cells incubated up to 48 hours with 38.5 µg/mL of 7-DHC indicated a not 
significant release of this enzyme from cells, thus excluding a necrotic 
process induced by 7-DHC (Tab. 5). On the other hand, the effect of 7-
DHC on A2058 cells treated for 24 hours showed an early apoptotic event 
detected by an increment of Annexin+/PI− cells, as well as, a late 
apoptotic event was revealed by an increase of PI cell incorporation after 
48 hours, which became more evident after 72 hours of treatment (Fig. 
4a,b). The apoptotic effect was also observed on SAN cells treated for 48 
hours with 38.5 µg/mL of 7-DHC (Fig. 5). It is worth to note that during 
caspase dependent apoptosis PARP-1 is cleaved by caspase-3 [37]. The 
results obtained in A2058 7-DHC treated cells didn’t show significant 
variation of caspase-3 activity as well as the cleavage of PARP-1 (Fig. 6). 
Hence, these results suggest that 7-DHC affects the viability of A2058 
melanoma cell lines via an apoptotic process, which may occurs in a 
caspase-independent manner.  
Our study indicates that 7-DHC entered rapidly A2058 cells (more than 
80% after 12 hours of treatment). This influx may contribute to alter the 
steady state of cholesterol in the membranes of cell compartments, 
impairing the lipid rafts, and may contribute to trigger the production of 
ROS affecting the cellular redox state. The 7-DHC may also alter the 
permeability of mitochondrial membrane and, not least, may generate 
oxidized sterol derivatives [38,45]. Hence, to analyze the molecular 
mechanisms through which the 7-DHC exerts its cytotoxic effect in 
A2058 melanoma cells, we have measured the intracellular levels of 
ROS, GSH, and the GSH/GSSG ratio during 7-DHC treatment. The ROS 
production increases significantly as early as after 2 hours of incubation, 
and the increase is still significant up to 8 hours of treatment (Fig. 7a). In 
addition, 7-DHC treatment of melanoma cells impairs the intracellular 
redox state as demonstrated by the reduction of GSH levels and 
GSH/GSSG ratio after 2 hours of treatment (Fig. 7c). If melanoma cells 
were pre-treated with NAC as antioxidant or apocynin as inhibitor of 
NADPH oxidase, ROS production induced by 7-DHC was inhibited (Fig. 
7b). Therefore, the modulation of ROS and GSH levels by 7-DHC 
treatment represents an early event that may affect cell viability. In fact, 
in A2058 cells pre-treated with NAC or apocynin, the apoptotic effect of 
7-DHC was significantly reduced (Fig. 8). Therefore, the alteration of 
intracellular redox state observed during 7-DHC treatment could 
represent an event that contributes to modulate the cytotoxic effect of 7-
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DHC on melanoma cells. Since this reduction is significant but 
incomplete, we believe that further investigations should be addressed to 
search other mechanisms involved in the cytotoxic effect of 7-DHC. 
The mitochondria play a key role in activating apoptosis in mammalian 
cells. Mitochondrial respiratory chain is the primary source of cellular 
ROS, therefore, the mitochondria are the main targets of ROS detrimental 
effects. In particular, the major ROS target inside mitochondria is 
undoubtedly the permeability transition pore (PTP). In response to some 
pro-apoptotic stimuli the PTP assumes a high conductance that results in 
the dissipation of mitochondrial membrane potential (MMP), an event 
that triggers the mitochondria dysfunctions [39]. The reduction of 
mitochondrial membrane potential observed in our experiments (Fig. 9) 
represents a clear signal of an involvement of mitochondria in the 
apoptotic process during 7-DHC treatment.  
Bcl-2 family proteins regulate cell death along the mitochondrial 
apoptosis pathway [40], playing a pivotal role in the control of MMP 
[46]. In particular, Bax and Bak act on mitochondria permeability, mostly 
at the mitochondrial outer membrane, by permeabilizing the vesicles that 
are composed of lipids [47]. Conversely, Bcl-2 and others anti-apoptotic 
Bcl-2 family members prevent the mitochondrial outer membrane 
permeabilization, by sequestering some pro-apoptotic proteins Bcl-2 like 
[47]. Hence, we analyzed the protein levels of the anti-apoptotic Bcl-2, 
pro-apoptotic Bax, Bcl-2/Bax ratio, as well as the cellular localization of 
Bax. The reduction of Bcl-2/Bax ratio, detected in A2058 melanoma cells 
treated with 7-DHC, resulted from an unchanged Bcl-2 levels and an 
increase of Bax levels detected both in cytosolic and mitochondrial 
fractions (Fig. 10). These data prompt us to speculate that 7-DHC, 
affecting both Bax levels and its mitochondrial translocation, alters the 
fine balance between pro-apoptotic and anti-apoptotic factors thus 
predisposing melanoma cells to cell death.  
It is to note that the alteration of mitochondrial membrane potential can 
make the outer mitochondrial membrane more permeable. This causes the 
release of mitochondrial factors that mediate the cell death process in a 
caspase-dependent and/or -independent manner [47]. A significant 
increase of AIF, a main mediator of caspase-independent cell death [42], 
was found in A2058 cells incubated with 38.5 µg/mL 7-DHC for 24 hours 
(Fig. 11), as well as its nuclear translocation was detected by confocal 
analysis (Fig. 12). Hence, the rise of AIF protein level and its nuclear 
translocation, together with the absence of an increase of caspase-3 
activity and PARP-1 cleavage, suggest that the cytotoxic effects of 7-
DHC may be mainly due to a caspase-independent apoptotic process. 
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Therefore, if we take into account that a mix of oxysterol derivatives, 
coming from cholesterol and 7-DHC, were found, but their levels were 
very low, we suggest that the cytotoxic effect should be due mainly to the 
7-DHC alone. However, much of the cytotoxicity attributable to 
oxysterols is due to their ability to induce apoptosis, even if there is no 
universal mechanism responsible for oxysterol-induced apoptosis.  
Our results on the effects of 7-DHC on the melanoma cell lines could be 
explained by assuming that loading more sterols in cell membranes and/or 
changing the ratio between other-sterols/cholesterol generated a stress 
that induced the production of ROS, an event that alters the mitochondrial 
functionality. As also reported in this study, the increase of pro-apoptotic 
Bax protein affects the mitochondrial permeabilization, interacting with 
voltage-dependent anion channel/adenine nucleotide transporter, and 
provokes a release of some molecules, such as cytochrome c, apoptosis-
inducing factor (AIF), endonuclease G, smac/DIABLO, that activate both 
caspase-dependent and -independent cell death pathways [48]. Other 
studies have documented oxysterol impacts on the balance of cellular Bax 
vs Bcl-2/Bcl-xL levels [45,49], but no such effect was seen in 7β-OHC-
treated Caco-2 cells [50], suggesting an involvement of a Bax/Bcl-2 
independent apoptotic process. These debated observations illustrate well 
the variability in the pathways of cell death induced by different 
sterols/oxysterols employed in different model systems. 
In conclusion, in this study we have treated melanoma cells directly with 
7-DHC in dark conditions. Furthermore, thanks to the use of an accurate 
and effective method to transfer the 7-DHC into the cells we have 
minimized the non-enzymatic oxidation of compound. Hence, this is the 
first report in which the biological effects found in melanoma cells are 
mainly attributable to 7-DHC as such. However, we believe that further 
studies are needed to better clarify how and where the 7-DHC acts into 
the cells to provoke the effects observed in this study. 
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